Wall Street brokerages expect Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Rating) to report earnings of ($0.23) per share for the current quarter, Zacks reports. Two analysts have issued estimates for Cardiff Oncology’s earnings, with the highest EPS estimate coming in at ($0.21) and the lowest estimate coming in at ($0.24). Cardiff Oncology reported earnings of […]
Related Keywords
California , United States , William Blair , Cardiff Oncology Inc , Elkhorn Partners Limited Partnership , Zacks Investment Research , Manufacturers Life Insurance Company , Nasdaq , Invesco Ltd , Cardiff Oncology Company Profile Get Rating , Maxim Group , Citigroup Inc , Wall Street , Cardiff Oncology , Get Rating , Investment Research , Partners Limited Partnership , Oncology Company Profile , Polo Like Kinase , Nasdaq Crdf , Acrdf , Medical , Ratings , Consensus ,
comparemela.com © 2020. All Rights Reserved.